View Older Stories

Feb 19, 2026 09:38AM AbbVie (ABBV) Declares $1.73 Quarterly Dividend; 3% Yield

Feb 5, 2026 10:17AM Cantor Fitzgerald Reiterates Overweight Rating on Abbvie (ABBV)

Feb 5, 2026 07:36AM Bernstein: 'We Anticipate Abbvie (ABBV) To Be Down MSD Today'

Feb 4, 2026 02:21PM Abbvie (ABBV) PT Lowered to $228 at Evercore ISI

Feb 4, 2026 10:36AM AbbVie (ABBV) executive: Abbvie: peak sales for Parkinson's and migraine franchises could exceed $5 billion

Feb 4, 2026 08:04AM AbbVie beats Q4 expectations, shares dip

Feb 4, 2026 07:51AM AbbVie (ABBV) Tops Q4 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance

Feb 3, 2026 06:00PM AbbVie earnings preview: Bernstein expects another tightly framed outlook

Feb 3, 2026 08:02AM AbbVie submits vitiligo treatment application to FDA and EMA

Feb 2, 2026 05:12AM AbbVie (ABBV) call put ratio 2.3 calls to 1 put into quarter results

Jan 28, 2026 06:57AM Goldman Sachs Reiterates Neutral Rating on Abbvie (ABBV) Ahead of Earnings

Jan 27, 2026 04:48PM Eli Lilly, Pfizer, AbbVie drugs targeted in third Medicare price talks

Jan 21, 2026 10:00AM This U.S. biotech stock is Bernstein's Top Pick for 2026

Jan 20, 2026 09:31AM Bernstein Reiterates Market Perform Rating on Abbvie (ABBV)

Jan 15, 2026 08:25AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV)

Jan 13, 2026 10:07AM UBS Reiterates Neutral Rating on Abbvie (ABBV)

Jan 12, 2026 06:35PM AbbVie (ABBV) and Trump Administration Reach Agreement To Cut Drug Prices, $100 bln Investment

Jan 12, 2026 07:30AM AbbVie licenses cancer drug from RemeGen for $650 million upfront

Jan 9, 2026 07:46AM HSBC lists 11 potential U.S. outperformers heading into earnings

Jan 8, 2026 03:44PM Merck (MRK) in Talks to buy Revolution Medicines (RVMD) - FT

Jan 8, 2026 11:22AM AbbVie (ABBV) call put ratio 1.3 calls to 1 put into the annual J.P. Morgan Healthcare Conference

Jan 8, 2026 08:39AM Merck upgraded on post-Keytruda growth, AbbVie cut as upside baked in - Wolfe

Jan 8, 2026 06:39AM Wolfe Research Downgrades Abbvie (ABBV) to Peerperform

Jan 7, 2026 04:59PM After-hours movers: Lockheed Martin, Canadian Solar, Revolution Medicines and more

Jan 7, 2026 04:14PM Abbvie: Not In Discussions With Revolution Medicines - Reuters

Jan 7, 2026 04:12PM AbbVie reports $1.3 billion Q4 expense from acquired research deals

Jan 7, 2026 02:50PM AbbVie in Advanced Talks to Buy Revolution Medicines - WSJ

Jan 7, 2026 03:14AM UBS Assumes Abbvie (ABBV) at Neutral

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 10, 2025 08:20AM HSBC highlights one pharma stock to buy and one to sell for 2026

Dec 10, 2025 02:04AM HSBC Upgrades Abbvie (ABBV) to Buy

Nov 28, 2025 07:01AM AbbVie's SKYRIZI receives positive reimbursement nod in Canada for UC

Nov 26, 2025 06:36AM Bernstein on IRA pricing: $245 really is the floor

Nov 5, 2025 01:50PM FDA issues warning letters to 18 websites selling unapproved Botox products

Nov 4, 2025 08:14AM Abbvie (ABBV) PT Raised to $225 at Bernstein SocGen Group

Nov 4, 2025 04:14AM DZ Bank Downgrades Abbvie (ABBV) to Hold

Nov 3, 2025 05:13AM Abbvie (ABBV) PT Raised to $256 at Raymond James

Oct 31, 2025 07:50AM AbbVie (ABBV) Tops Q3 EPS by 8c, Beats on Revenue; Offers FY25 EPS Guidance

Oct 31, 2025 06:00AM Analysts expect AbbVie’s core franchises to offset R&D costs ahead of Q3 earnings

Oct 31, 2025 04:22AM AbbVie (ABBV) call put ratio 1 call to 1 put into quarter results

Oct 30, 2025 10:56AM AbbVie (ABBV) call put ratio 1.8 calls to 1 put into quarter results

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 20, 2025 08:05AM Abbvie (ABBV) PT Raised to $258 at BMO Capital

Oct 20, 2025 08:00AM AbbVie's RINVOQ outperforms HUMIRA in rheumatoid arthritis study

Oct 20, 2025 07:22AM Abbvie (ABBV) PT Raised to $242 at Guggenheim, 'Looking for Additional Treats on Halloween to Drive Further Upside'

Oct 17, 2025 05:17AM Abbvie (ABBV) PT Raised to $250 at Raymond James

Oct 14, 2025 06:52AM Cantor Fitzgerald Notes IPR&D Charge Impact on Abbvie's (ABBV) 3Q EPS

Oct 13, 2025 04:03PM Erste Group Downgrades Abbvie (ABBV) to Hold

Oct 13, 2025 10:58AM FDA approves expanded RINVOQ indication for inflammatory bowel disease

View Older Stories